Suppr超能文献

诊断性血液培养管理对危重症儿童的影响:与培养率、抗生素使用和患者结局的关联:BRIGHT STAR 协作研究结果。

Association of Diagnostic Stewardship for Blood Cultures in Critically Ill Children With Culture Rates, Antibiotic Use, and Patient Outcomes: Results of the Bright STAR Collaborative.

机构信息

Division of Critical Care Medicine, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia.

Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia.

出版信息

JAMA Pediatr. 2022 Jul 1;176(7):690-698. doi: 10.1001/jamapediatrics.2022.1024.

Abstract

IMPORTANCE

Blood culture overuse in the pediatric intensive care unit (PICU) can lead to unnecessary antibiotic use and contribute to antibiotic resistance. Optimizing blood culture practices through diagnostic stewardship may reduce unnecessary blood cultures and antibiotics.

OBJECTIVE

To evaluate the association of a 14-site multidisciplinary PICU blood culture collaborative with culture rates, antibiotic use, and patient outcomes.

DESIGN, SETTING, AND PARTICIPANTS: This prospective quality improvement (QI) collaborative involved 14 PICUs across the United States from 2017 to 2020 for the Bright STAR (Testing Stewardship for Antibiotic Reduction) collaborative. Data were collected from each participating PICU and from the Children's Hospital Association Pediatric Health Information System for prespecified primary and secondary outcomes.

EXPOSURES

A local QI program focusing on blood culture practices in the PICU (facilitated by a larger QI collaborative).

MAIN OUTCOMES AND MEASURES

The primary outcome was blood culture rates (per 1000 patient-days/mo). Secondary outcomes included broad-spectrum antibiotic use (total days of therapy and new initiations of broad-spectrum antibiotics ≥3 days after PICU admission) and PICU rates of central line-associated bloodstream infection (CLABSI), Clostridioides difficile infection, mortality, readmission, length of stay, sepsis, and severe sepsis/septic shock.

RESULTS

Across the 14 PICUs, the blood culture rate was 149.4 per 1000 patient-days/mo preimplementation and 100.5 per 1000 patient-days/mo postimplementation, for a 33% relative reduction (95% CI, 26%-39%). Comparing the periods before and after implementation, the rate of broad-spectrum antibiotic use decreased from 506 days to 440 days per 1000 patient-days/mo, respectively, a 13% relative reduction (95% CI, 7%-19%). The broad-spectrum antibiotic initiation rate decreased from 58.1 to 53.6 initiations/1000 patient-days/mo, an 8% relative reduction (95% CI, 4%-11%). Rates of CLABSI decreased from 1.8 to 1.1 per 1000 central venous line days/mo, a 36% relative reduction (95% CI, 20%-49%). Mortality, length of stay, readmission, sepsis, and severe sepsis/septic shock were similar before and after implementation.

CONCLUSIONS AND RELEVANCE

Multidisciplinary diagnostic stewardship interventions can reduce blood culture and antibiotic use in the PICU. Future work will determine optimal strategies for wider-scale dissemination of diagnostic stewardship in this setting while monitoring patient safety and balancing measures.

摘要

重要性

儿科重症监护病房(PICU)中血液培养的过度使用会导致不必要的抗生素使用,并导致抗生素耐药性。通过诊断管理优化血液培养实践,可以减少不必要的血液培养和抗生素。

目的

评估由 14 个多学科 PICU 组成的血液培养合作与培养率、抗生素使用和患者结局之间的关系。

设计、地点和参与者:这项前瞻性质量改进(QI)合作涉及美国 2017 年至 2020 年的 14 个 PICUs,参与了 Bright STAR(测试管理减少抗生素)合作。从每个参与的 PICU 以及儿童保健协会儿科健康信息系统收集了数据,以用于规定的主要和次要结果。

暴露

一项专注于 PICU 血液培养实践的本地 QI 计划(由更大的 QI 合作提供便利)。

主要结果和措施

主要结果是血液培养率(每 1000 患者日/月)。次要结果包括广谱抗生素使用(总治疗天数和新开始使用广谱抗生素≥3 天)和 PICU 中心静脉相关血流感染(CLABSI)、艰难梭菌感染、死亡率、再入院、住院时间、败血症和严重败血症/感染性休克的发生率。

结果

在 14 个 PICU 中,实施前的血液培养率为每 1000 患者日/月 149.4 次,实施后的血液培养率为每 1000 患者日/月 100.5 次,相对减少了 33%(95%CI,26%-39%)。与实施前后的时间段相比,广谱抗生素使用的比率从 506 天降至 440 天/1000 患者日/月,相对减少了 13%(95%CI,7%-19%)。广谱抗生素起始率从 58.1 次降至 53.6 次/1000 患者日/月,相对减少了 8%(95%CI,4%-11%)。CLABSI 的发生率从每 1000 个中心静脉置管日 1.8 次降至 1.1 次,相对减少了 36%(95%CI,20%-49%)。死亡率、住院时间、再入院、败血症和严重败血症/感染性休克在实施前后相似。

结论和相关性

多学科诊断管理干预措施可以减少 PICU 中的血液培养和抗生素使用。未来的工作将确定在这种情况下更广泛地传播诊断管理的最佳策略,同时监测患者安全并平衡措施。

相似文献

2
Practices, Perceptions, and Attitudes in the Evaluation of Critically Ill Children for Bacteremia: A National Survey.
Pediatr Crit Care Med. 2020 Jan;21(1):e23-e29. doi: 10.1097/PCC.0000000000002176.
3
Diagnostic stewardship for blood cultures in the pediatric intensive care unit: lessons in implementation from the BrighT STAR Collaborative.
Antimicrob Steward Healthc Epidemiol. 2024 Sep 25;4(1):e148. doi: 10.1017/ash.2024.416. eCollection 2024.
4
Association of a Clinical Practice Guideline With Blood Culture Use in Critically Ill Children.
JAMA Pediatr. 2017 Feb 1;171(2):157-164. doi: 10.1001/jamapediatrics.2016.3153.
5
Health Care-Associated Infections Among Critically Ill Children in the US, 2013-2018.
JAMA Pediatr. 2020 Dec 1;174(12):1176-1183. doi: 10.1001/jamapediatrics.2020.3223.
6
Application of Participatory Ergonomics to the Dissemination of a Quality Improvement Program for Optimizing Blood Culture Use.
Jt Comm J Qual Patient Saf. 2023 Oct;49(10):529-538. doi: 10.1016/j.jcjq.2023.06.004. Epub 2023 Jun 10.
9
Antibiotic Stewardship Practices and Prescribing Patterns Across Indian PICUs.
Indian J Pediatr. 2022 Sep;89(9):872-878. doi: 10.1007/s12098-021-03929-9. Epub 2021 Dec 2.
10
Antimicrobial Stewardship in Bronchiolitis: A Retrospective Cohort Study of Three PICUs in Canada.
Pediatr Crit Care Med. 2022 Mar 1;23(3):160-170. doi: 10.1097/PCC.0000000000002834.

引用本文的文献

1
2
Diagnostic Stewardship of Blood Cultures in the Pediatric ICU Using Machine Learning.
Hosp Pediatr. 2025 Jun 1;15(6):e240-e244. doi: 10.1542/hpeds.2024-008235.
3
Use of procalcitonin in therapeutic decisions in the pediatric intensive care unit.
Ann Intensive Care. 2025 Apr 23;15(1):55. doi: 10.1186/s13613-025-01470-y.
4
Bacteremia in Pediatric Solid Organ Transplant Recipients within 1 Year of Transplant.
Transpl Infect Dis. 2025 Apr 21;27(4):e70030. doi: 10.1111/tid.70030.
5
(Un)Sustainable Science: Greening Practices in Research, Clinical Microbiology, and Veterinary Laboratories Locally and Globally.
Open Forum Infect Dis. 2025 Jan 10;12(2):ofae677. doi: 10.1093/ofid/ofae677. eCollection 2025 Feb.
6
Ancillary Benefit of Microbiology Culture Diagnostic Stewardship: Decreasing Health Care's Climate Impact.
Open Forum Infect Dis. 2024 Jul 3;12(2):ofae368. doi: 10.1093/ofid/ofae368. eCollection 2025 Feb.
7
Opportunities for collaboration: the synergy between antimicrobial and diagnostic stewardship in pediatrics.
Antimicrob Steward Healthc Epidemiol. 2025 Feb 7;5(1):e32. doi: 10.1017/ash.2024.464. eCollection 2025.
8
Blood Culture Use in Medical and Surgical Intensive Care Units and Wards.
JAMA Netw Open. 2025 Jan 2;8(1):e2454738. doi: 10.1001/jamanetworkopen.2024.54738.
9
Blood culture bottle shortage mitigation efforts: analysis of impact on ordering and patient impact.
Antimicrob Steward Healthc Epidemiol. 2025 Jan 9;5(1):e6. doi: 10.1017/ash.2024.474. eCollection 2025.
10
Diagnostic Stewardship Is Environmental Stewardship.
J Grad Med Educ. 2024 Dec;16(6 Suppl):53-57. doi: 10.4300/JGME-D-24-00118.1. Epub 2024 Dec 13.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验